Intended for healthcare professionals

CCBYNC Open access

Rapid response to:

Research

Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study

BMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k119 (Published 06 February 2018) Cite this as: BMJ 2018;360:k119

Rapid Response:

Effect Size

Relative measures have their obvious importance, but absolute measures are easier to understand when it comes time to prescribe.

Could the authors also kindly report benefit as an absolute measure over time, NNT if possible.

Thank you

Competing interests: No competing interests

08 February 2018
Piero Baglioni
Consultant Physician
Prince Charles Hospital
Gournos, Merthyr Tydfill